Q&A with Avingtrans CEO, Steve McQuillan & CFO Stephen King
In this upbeat interview, CEO Steve McQuillan & CFO Stephen King of Avingtrans take me through today’s positive and in line H1’26 results – including:
00:00 Secular growth drivers (eg new nuclear, data centres & defence), client demand & possible capacity expansion
11:25 H1’26 financial highlights
16:55 Progress with medical division (re Adaptix, Magnetica and Scientific Magnets)
24:00 Timescales for potential future exits (eg Hayward Tyler and Ormandy)
29:10 FY26 & FY27 outlook alongside closing remarks
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
